Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Preceptorship on Supportive and Palliative Care

ESMO Preceptorship on Supportive and Palliative Care Lugano 2019 banner
Start date
01 Feb 2019
End date
02 Feb 2019
Lugano, Switzerland

Learning objectives

  • Understand mechanisms of the key symptoms and syndromes pain, fatigue, anorexia, dyspnea, nausea, vomiting, diarrhea, skin toxicities, mucositis, and their association with cancer-disease and anticancer-treatment
  • Describe main pharmacological, physical, educational, communicative and coordinating interventions for management of cachexia and other key symptoms and syndromes
  • Understand integration of screening for and assessment of anticancer toxicities, symptoms and other palliative and supportive care needs, and integration of their management in routine oncology care
  • Describe required competences of multidisciplinary and inter-professional teams for multimodal management
  • Understand key steps to prepare patients and family members for end-of-life and care of the dying person
  • Understand the risk, prevention and management of venous thromboembolism, febrile neutropenia, anaemia and bone complications in cancer patients
  • Understand how to communicate with patients about illness, prognosis, coping, hope, and decisions, reflect about your own role, and how to address cultural differences
  • Know the ESMO Clinical Practice Guidelines relevant for the topics discussed

Download the programme


The programme of this event has been accredited with 10 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.


  • Karin Jordan, Germany
  • Florian Strasser, Switzerland

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.